Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Battista, Marco Johannes; Schnatz, Carola; Almstedt, Katrin et al.

Low-dose metronomic chemotherapy (LDMC) as an efficient treatment option in metastatic breast cancer: Results of an exploratory case-control study.

JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019


Polterauer, Stephan; Schwameis, Richard; Grimm, Christoph et al.

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study

GYNECOLOGIC ONCOLOGY. Bd. 153. H. 2. 2019 S. 286-291


Bartsch, F.; Heinrich, S.; Roth, W. et al.

Lymphadenectomy in oncological visceral surgery-Part 1. Hepatobiliary tumors and pancreatic cancer

CHIRURG. Bd. 90. H. 5. 2019 S. 423-436


Kauff, D. W.; Babic, B.; Grimminger, P. P. et al.

Lymphadenectomy in oncological visceral surgery-Part 2 Cancer of the upper and lower intestinal tract

COLOPROCTOLOGY. Bd. 41. H. 4. 2019 S. 293-309


Kauff, D. W.; Babic, B.; Grimminger, P. P. et al.

Lymphadenectomy in oncological visceral surgery-Part 2. Cancer of the upper and lower intestinal tract

CHIRURG. Bd. 90. H. 6. 2019 S. 505-521


Weikel, W

Lymphonodektomie beim Vulvakarzinom: Wann und wie vorgehen?

Frauenheilkunde up2date. Bd. 13. H. 4. 2019 S. 355-365


Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail et al.

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

FUTURE ONCOLOGY. Bd. 15. H. 6. 2019 S. 567-577



Ruecker, Frank G.; Agrawal, Mridul; Corbacioglu, Andrea et al.

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

BLOOD. Bd. 134. H. 19. 2019 S. 1608-1618


Schlenk, Richard F.; Weber, Daniela; Fiedler, Walter et al.

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

BLOOD. Bd. 133. H. 8. 2019 S. 840-851